Status:
COMPLETED
Descriptive Study of Acute Spontaneous Spinal Cord Infarction
Lead Sponsor:
University Hospital, Montpellier
Collaborating Sponsors:
Centre Hospitalier Universitaire de Nīmes
Conditions:
Spinal Cord Infarction
Spinal Cord Stroke
Eligibility:
All Genders
18+ years
Brief Summary
Acute spontaneous Spinal Cord Infarctions (SCI) are an uncommon cause of myelopathy (5%), but their prognostic is heterogeneous and frequently severe. Positive diagnosis is difficult, one quarter of i...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Hospitalized patients in a medical ward in Montpellier and Nîmes University Hospitals with registered diagnosis of vascular myelopathy
- And final diagnosis of spontaneous SCI after reviewing medical datas
- Exclusion criteria:
- non ischemic myelopathies : compression, hematomyelia, spinal DAVF, intramedullary tumor, inflammatory, infectious or post-infectious myelitis, post-radiation myelopathy,…)
- secondary SCI : SCI following an aortic, cardiac or rachidian surgery, extracorporeal circulation, post-hemodynamic shock
- SCI without a cause
Exclusion
Key Trial Info
Start Date :
May 30 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04372758
Start Date
May 30 2020
End Date
January 1 2021
Last Update
June 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uhmontpellier
Montpellier, France, 34295